Indivior Pharmaceuticals Inc. (INDV) is on the Move, Here's Why the Trend Could be SustainableZacks Investment Research • 06/29/26
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and MarkerZacks Investment Research • 06/26/26
INDV and the Shift to Long-Acting Opioid Use Disorder Care in 2026Zacks Investment Research • 06/12/26
Recent Price Trend in Indivior Pharmaceuticals Inc. (INDV) is Your Friend, Here's WhyZacks Investment Research • 06/12/26
5 Top-Ranked Efficient Stocks Beating Industry Peers on Key MetricsZacks Investment Research • 06/02/26
Does Indivior Pharmaceuticals Inc. (INDV) Have the Potential to Rally 32.48% as Wall Street Analysts Expect?Zacks Investment Research • 05/21/26
New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare UtilizationGlobeNewsWire • 05/20/26
Indivior Pharmaceuticals Inc. (INDV) Is a Great Choice for 'Trend' Investors, Here's WhyZacks Investment Research • 05/18/26
Bears are Losing Control Over Indivior Pharmaceuticals Inc. (INDV), Here's Why It's a 'Buy' NowZacks Investment Research • 05/14/26
Medical Stock In Buy Zone After Breakout By Opioid-Addiction Treatment MakerInvestors Business Daily • 05/12/26
Indivior Pharmaceuticals Inc. (INDV) is a Great Momentum Stock: Should You Buy?Zacks Investment Research • 05/05/26
Indivior Pharmaceuticals Inc. (INDV) Upgraded to Strong Buy: Here's What You Should KnowZacks Investment Research • 05/05/26
Wall Street Analysts Predict a 27.76% Upside in Indivior Pharmaceuticals Inc. (INDV): Here's What You Should KnowZacks Investment Research • 05/05/26
Here's Why Momentum in Indivior Pharmaceuticals Inc. (INDV) Should Keep goingZacks Investment Research • 05/01/26
Indivior Pharmaceuticals Inc. (INDV) Q1 Earnings and Revenues Beat EstimatesZacks Investment Research • 04/30/26